Dr. Paul Mattick Q&A with Chris Kilroy of Mercia’s EIS Funds

Join Dr Paul Mattick, Head of sales and investor relations at Mercia, and Chris Kilroy of the Mercia EIS investment team, who answer questions surrounding the impact of COVID-19 on Mercia’s EIS Funds, how its impacted the valuation and how Mercia are supporting their portfolio companies in the next period.